DUBLIN, Aug. 7, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Regenerative Medicine Market in the US 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
The Regenerative Medicine market in the US has witnessed a number of mergers and acquisitions by leading vendors in the past few years. Vendors are focusing on mergers and acquisitions to strengthen their global position and increase their commercial capabilities. For instance, in November 2012, Smith & Nephew acquired Healthpoint Biotherapeutics for US$782 million. Also, in January 2011, NeoStem acquired Progenitor Cell Therapy and in May 2011, Shire acquired Advanced BioHealing for US$750 million. These acquisitions have resulted in a better vendor product portfolio and have a positive impact on the growth of the market.
According to the report, the Regenerative Medicine market in the US is driven by several factors, of which the increasing prevalence of degenerative diseases is one of the major drivers. Regenerative medicine offers the chance to find favorable therapies for chronic diseases. Stem cell therapies are increasingly being applied in various medical conditions as they help in restoring body functions and improving the quality of a patient's life. This increased application of stem cell therapies in various medical conditions is driving the growth of the Regenerative Medicine market in the US.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Application
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
16. Key Vendor Analysis
17. Other Reports in this Series
Companies Mentioned:
- Aastrom Biosciences
- Acologix
- Advanced Cell Technology
- Arteriocyte
- Athersys
- AvitaMedical Ltd.
- Baxter International
- CytomedixInc.
- Cytori Therapeutics
- Fibrocell Science
- Forticell Bioscience
- GE Healthcare
- Johnson and Johnson Ltd.
- Kinetic Concepts
- Medtronic
- Organogenesis
- Osiris Therapeutics
- Osteotech
- Pluristem Therapeutics
- RTI Biologics
- ReNeuron Group plc
- SanBio
- StemCells
- Stryker Corp.
- Tengion
- Thermo Fischer Scientific
- Tissue Genesis
- ViaCyteInc.
For more information visit http://www.researchandmarkets.com/research/pz5qgf/regenerative
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
